Interaction between Aβ and Tau in the Pathogenesis of Alzheimer’s Disease

Cited by (685)

Items 301–400 of 685

1. Histone Deacetylase 2 in Alzheimer’s Disease: A Comprehensive Molecular Blueprint for Therapeutic Targeting
   Kavuma Asadi, Radha K., Sairaj Satarker, Prasada Chowdari Gurram · 2025 · Molecular Neurobiology
2. Taurine suppresses Aβ aggregation and attenuates Alzheimer’s disease pathologies in 5XFAD mice and patient-derived cerebral organoids
   Hyewon Lee, Muhammad Kamal Hossain, Hwa-Young Lee, Vijay Kumar, Soo Jung Shin, Byeong‐Hyeon Kim, Hyun Ha Park, Jeong Gyu Son, Minho Moon, Hyung‐Ryong Kim · 2025 · Biomedicine & Pharmacotherapy
3. Astrocyte response in Alzheimer’s disease: Good or bad?
   Alaa Ismail, Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Ali K. Albuhadily, Asmaa S. A. Yassen, Athanasios T. Alexiou, Marios Papadakis, Gaber El‐Saber Batiha · 2025 · Brain Research
4. Nanozymes - A new opportunity for the treatment of neurodegenerative diseases
   Yiqi Zhou, Xuan Zhou, Yanyan Song, Qi Tian, Shanhe Li, Tingting Li, Xiu Fang Lu · 2025 · Chemical Engineering Journal
5. Next-generation neurotherapeutics: mechanistic insights on monoclonal antibodies in Alzheimer’s disease
   Akhil Sharma, Thakur Gurjeet Singh · 2025 · Brain Research
6. Mesoporous PdPt Nanozymes with Target Peptides and Cascade Reactive Oxygen Species Scavenging for Boosting Alzheimer’s Disease Treatment
   Xiaoli Cai, Yuteng Huang, T X Wang, Jie Gao, Yinjun Tang, Chengzhou Zhu, Shuang Rong · 2025 · ACS Nano
7. Neuroimmune dysregulation in Alzheimer's disease: Mechanisms and therapeutic strategies
   Haili He, Shijie Zhu, Can Zhang, Hongyan Wang, Yuan Li, Haibing Qian · 2026 · Ageing Research Reviews
8. Erjingwan and Alzheimer’s disease: research based on network pharmacology and experimental confirmation
   Yuya Xu, Jian Zhang, Xuling Li · 2024 · Frontiers in Pharmacology
9. Selenium ameliorates cognitive impairment through activating BDNF/TrkB pathway
   Yu Liu, Ye Liu, Liping Shi, Xue Zhang, Kunmei Liu, Shulan He · 2025 · Journal of Trace Elements in Medicine and Biology
10. Integrative network analysis reveals novel moderators of Aβ-Tau interaction in Alzheimer's disease
    Kitani, Akihiro, Matsui, Yusuke, for the Alzheimer’s Disease Neuroimaging Initiative · 2025 · Alzheimer's Research & Therapy
11. Intranasal insulin in Alzheimer disease (diabetes in situ?): a systematic review and meta-analysis
    Luís Jesuíno de Oliveira Andrade, Gabriela Correia Matos de Oliveira, Luís Matos de Oliveira · 2025 · Dementia & Neuropsychologia
12. Sex differences in clinical risk factors for Alzheimer's dementia patients with early-onset and late-onset
    Nathan Gerhard Faulstich, Sammy Hilmi Omar, Claire O’Brien, Dami Taiwo Ojo, Philip Cole Brewer, Emmanuel I. Nathaniel, Richard L. Goodwin, Laurie Theriot Roley, Adebobola Imeh‐Nathaniel, Thomas I. Nathaniel · 2025 · Frontiers in Global Women s Health
13. DHEC mesylate attenuates pathologies and aberrant bisecting N-glycosylation in Alzheimer's disease models
    Yue Wang, Yiming Cao, Hongfei Huang, Yue Xue, Song Chen, Xiangdong Gao · 2024 · Neuropharmacology
14. Fosgonimeton attenuates amyloid-beta toxicity in preclinical models of Alzheimer's disease
    Sherif M. Reda, Sharay E. Setti, Andrée‐Anne Berthiaume, Wei Wu, Robert W. Taylor, Jewel L. Johnston, Liana Roberts Stein, Hans J. Moebius, Kevin J. Church · 2024 · Neurotherapeutics
15. Molecular dynamics of amyloid-β transport in Alzheimer's disease: Exploring therapeutic plasma exchange with albumin replacement – Current insights and future perspectives
    R. Mondal, Shramana Deb, Gourav Shome, Vramanti Sarkar, Durjoy Lahiri, S.S. Datta, Julián Benito‐León · 2024 · Neurología
16. Deciphering Early and Progressive Molecular Signatures in Alzheimer’s Disease through Integrated Longitudinal Proteomic and Pathway Analysis in a Rodent Model
    Hamad Yadikar, Mubeen A. Ansari, Mohamed Abu‐Farha, Shibu Joseph, Betty T. Thomas, Fahd Al‐Mulla · 2024 · International Journal of Molecular Sciences
17. Near-infrared laser diode mitigates Aβ1–42-induced neurodegeneration in cortical neurons
    Min Ji Kim, Mi-Hye Kim, Sehwan Kim, Jung Jae Lee, Hee Jung Kim · 2024 · Journal of Photochemistry and Photobiology B Biology
18. CD28+ CD45RA− CD8br AC mediated the effects of Interleukin- 6 on Alzheimer's disease: A Mendelian Randomization Study
    Rui‐Hua Xu, YongJun Gao · 2025 · BMC Neurology
19. Cross-talk between amyloid beta peptides and tau proteins in Co-aggregation investigating with the combination of coarse-grained and all-atom simulations
    Hao Shang, Mengqi Duan, Chaohong Da, Xinyi Fu, Tao Zhang · 2025 · International Journal of Biological Macromolecules
20. Berberine's paradox in Neurodegeneration: Therapeutic promise and safety challenges in Parkinson's disease
    Sultan Mohammed Alshahrani, Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Ali K. Albuhadily, Mohamed N Fawzy, Sultan F. Kadasah, Mubarak Alruwaili, Marios Papadakis, Athanasios T. Alexiou, Gaber El‐Saber Batiha · 2025 · Neuropharmacology
21. Exploration of Asparagus racemosus Willd for Alzheimer’s Disease Through Integrated Metabolomics and Network Pharmacology Analyses Targeting BACE1 Protein
    Vineetha Shaji, S Amrutha, Ravishankar Pervaje, Chandran Sheela Abhinand, Rajesh Raju, Thottethodi Subrahmanya Keshava Prasad, Prashant Kumar Modi · 2025 · Neurochemical Research
22. Cognitive impairment and risk of dementia in heart failure: the exuberating role of digoxin
    Hayder Mutter Al-Kuraishy, Esraa Hammadi Fahad, Ghassan Mohammad Sulaiman, Hamdoon Abdelhamid Mohammed, Majid Sakhi Jabir, Ali Ismail Al-Gareeb, Ali K. Albuhadily · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
23. Therapeutic Potential of Sea Cucumber-Derived Bioactives in the Prevention and Management of Brain-Related Disorders: A Comprehensive Review
    Purnima Rani Debi, Hrishika Barua, Mirja Kaizer Ahmmed, Shuva Bhowmik · 2025 · Marine Drugs
24. Phytocompounds as modulators of HSF1 in neurodegenerative disease: Special emphasis on Alzheimer's disease
    Vinod Kumar Nelson, Mohammed Yasmin Begum, Ayed A. Dera, Syed Parween Ali, Punna Rao Suryadevara · 2025 · European Journal of Pharmacology
25. Ampholytic Carbon Dots Enable Imaging and Modulation of Amyloid Fibrillation with Reduced Neurotoxicity
    Suman Mandal, Santanu Shaw, Saikat Kumar Pandit, Puja Garai, Nikhil Ranjan Jana · 2025 · Nano Letters
26. Research progress of exosomes used in the Alzheimer's disease treatment
    Xiaoqin Gao, Ke Yang, Xiaokui Yuan, Mengyuan Song, Tong Wang, Chenlan Shen · 2025 · Discover Nano
27. The Synergistic Role of ApoE4 and GSK3β in Alzheimer’s Disease: Pathological Mechanisms and Therapeutic Implications
    Qianwei Li, Yinghui Shang, Han‐Chang Huang, Xueling Dai, Fengxue Lao · 2025 · Molecular Neurobiology
28. PANoptosis inhibition by Morchella sextelata polysaccharide mediates neuroprotection in Alzheimer's disease models
    Chunyue Wang, Yue Guan, Jiaqi Chen, Siqi Liu, Haomei Li, Shimiao Wang, Y. e Liang Zhang, Yu Li, Yang Liu, Lanzhou Li et al. · 2026 · International Journal of Biological Macromolecules
29. Tau Protein Aggregation Inhibitors—Therapeutic Strategy for Concurrent Tau and Amyloid Aggregation Inhibition
    Thomas Gabriel Schreiner, Romeo Cristian Ciobanu, Oliver Daniel Schreiner · 2026 · Biomedicines
30. Copper Homeostasis and Cuproptosis in Neurological Disorders
    Wu Liu, Yan Xue, Chenyin Cao, Liting Yang, Lijun Zhang · 2026 · Drug Design Development and Therapy
31. The evolving landscape of amyloid-targeting therapies in Alzheimer’s disease: progress and challenges
    Binbin Zhang, Xiaoyun Yu, Xin Zhang · 2026 · Neurological Sciences
32. Medicinal chemistry approaches for dual inhibition of amyloid-β and tau aggregation in Alzheimer’s disease
    Jatin Jangra, Isha Mahindru, Aman Kumar, Harikesh Kumar Gupta, Vishwakarma Krishna Ramesh, Rajnish Kumar · 2026 · Future Medicinal Chemistry
33. Multi‐Target‐Directed Ligands ( MTDLs ) as Potential Therapeutic Candidates Targeting Multiple Pathogenic Factor of Alzheimer's Disease
    Jaewoon Jung, Yebeen Kim, Asifiwe Clarisse Cirunduzi, Seonghyun Yoon, Seokyoung Bang, Seung‐Hoon Yang · 2026 · CNS Neuroscience & Therapeutics
34. Moringa oleifera leaves ethanolic extract counteracts cortical neurodegeneration induced by aluminum chloride in rats
    Rabab Fawzy Hindawy, Samia Manawy, Ola Elsayed Nafea, Abeer A. Abdelhameed, fatma fawzi hendawy · 2024 · Toxicology Research
35. Identifying the Role of Oligodendrocyte Genes in the Diagnosis of Alzheimer's Disease through Machine Learning and Bioinformatics Analysis
    Yan Chen, Chen Li, Yinhui Yao, Shang Yazhen · 2024 · Current Alzheimer Research
36. An overview in interactions and biosensors of multiple biomarkers of Alzheimer’s disease
    Xuyuan Chen, Wei Y, Xiaobing Wang, Xiangping Liu, Xiaoying Wang · 2025 · Chemical Engineering Journal
37. Repurposing of cabergoline to improve cognitive decline in D-galactose-injected ovariectomized rats: Modulation of AKT/mTOR, GLT-1/P38-MAPK, and ERK1/2 signaling pathways
    Sheer A. Joodi, Mahmoud Mohamed Khattab, Weam W. Ibrahim · 2025 · Toxicology and Applied Pharmacology
38. Wnt/β-catenin Pathway Activation Reverses Tau Hyperphosphorylation and β-Amyloid Accumulation Induced by Combined Manganese and Iron Exposure in PC12 Cells
    Thanh-Tung Ho, Hai Huang, Yiling Li, Zhi-Xin Huang, Viet-Phuong-Nguyen Nguyen, Galal A Al-Samhari, Michael Aschner, Zhao-cong Li, Yue‐Ming Jiang · 2025 · Biological Trace Element Research
39. VRADA training system as a non-pharmacological dual intervention to alleviate symptoms of the pathophysiology of Mild Cognitive Impairment
    Eleni E. Tzekaki, Georgios Katsipis, Eleni G. Andreadou, Christos Mouzakidis, Eleni N. Baldimtsi, Eleni Maria Karathanasi, Mary Hassandra, Evangelos Galanis, Antonis Hatzigeorgiadis, Μάριος Γούδας et al. · 2023 · Brain Disorders
40. Delayed Reaction of Radiation on the Central Nervous System and Bone System in C57BL/6J Mice
    Yi Ru, Xianxie Zhang, Baoying Shen, Chunqi Yang, Huijing Yu, Zuoxu Liu, Xiangjun Wu, Fangyang Li, Jialu Cui, Chengcai Lai et al. · 2023 · International Journal of Molecular Sciences
41. The neuroinflammatory role of microRNAs in Alzheimer’s disease: pathological insights to therapeutic potential
    Wenjia Liu, Xin Rao, Wen Sun, Xiaodong Chen, Liyang Yu, Jiangtao Zhang, Jiong Chen, Xiaorong Zheng · 2024 · Molecular and Cellular Biochemistry
42. Influence of immune cells and inflammatory factors on Alzheimer’s disease axis: evidence from mediation Mendelian randomization study
    Linzhu, Jianxin Zhang, Wenhui Fan, Chen Su, Zhi Jin · 2025 · BMC Neurology
43. Zinc exacerbates tau-induced Alzheimer-like pathology in C57BL/6J mice
    Xuexia Li, Linfeng Le, Qingqing Shi, Hao Xu, Chao Wang, Yufang Xiong, Xun Wang, Guoli Wu, Qiong Liu, Xiubo Du · 2023 · International Journal of Biological Macromolecules
44. Role of Amyloidogenic and Non‐Amyloidogenic Protein Spaces in Neurodegenerative Diseases and their Mitigation Using Theranostic Agents
    Kapali Suri, Madhu Ramesh, Mansi Bhandari, Vishakha Gupta, Virendra Kumar, Thimmaiah Govindaraju, N. Arul Murugan · 2024 · ChemBioChem
45. What Information do Systemic Pathological Changes Bring to the Diagnosis and Treatment of Alzheimer’s Disease?
    Jinyue Zhou, Xiaoli Sun, Keren Wang, Min Shen, Jingbo Yu, Qi Yao, H. S. Hong, Chunlan Tang, Qinwen Wang · 2025 · Neuroscience Bulletin
46. Dual Aβ/tau epitope vaccines: a poorly explored strategy for Alzheimer's disease immunotherapy
    Karen León‐Arcia, Gabriela Pérez-Leal, Heidi Quintero-Álvarez, Diana Iris Zamora-Loyarte, Mailén López-Armenteros, Alexandra de la Caridad Sánchez-Quesada, Yaimeé Vázquez‐Mojena · 2025 · Vaccine
47. Neuroprotective Effect of Mixed Mushroom Mycelia Extract on Neurotoxicity and Neuroinflammation via Regulation of ROS-Induced Oxidative Stress in PC12 and BV2 Cells
    Sang-Seop Lee, Da-Hyun Ko, So-Yeon Kim, Ga-Young Lee, Seung Yun Han, Jong-Yea Park, M.S. Park, Hyun‐Min Kim, Ya-El Kim, Yung Choon Yoo · 2025 · Cells
48. Low-intensity transcranial ultrasound neuromodulation promotes neuronal regeneration: A new hope for noninvasive treatment of neurodegenerative diseases
    Shu Xia, Chen He, Yunfei Li, Hao Li, Bo Wang, Long Xu, Xudong Zhao · 2025 · Neural Regeneration Research
49. The role of the Mediterranean diet in the treatment of cognitive dysfunction in patients with type 2 diabetes mellitus
    Chunyan Zheng, Qinqin Zhang, Fengli Liu, Guihong Qiu · 2025 · Frontiers in Nutrition
50. Genetic and epigenetic drivers of neurodegenerative disorders
    Kanad Roy, Muskan Syed, Priyanka Narad, Abhishek Sengupta · 2025 · Progress in brain research
51. Identification of novel DYRK1A inhibitors as treatment options for alzheimer’s disease through comprehensive in silico approaches
    Ibrahim Akindeji Makinde, Sheriffdeen Oladimeji Hammed, Neeraj Kumar, Najwa Ahmad Kuthi, Haruna Isiyaku Umar, Temitayo Abidat Hassan, Idayat Oyinkansola Kehinde, Ridwan Opeyemi Bello, Abdullahi Tunde Aborode, Tajudeen O. Jimoh et al. · 2025 · Scientific Reports
52. A Review on the Pathophysiology of Alzheimer’s Disease
    Uma Agarwal, Garima Talwar Kapoor, Rajiv Kumar Tonk · 2025 · Current Protein and Peptide Science
53. Maternal cadmium exposure promotes amyloid-beta pathology by interrupting the interaction of AQP1 and HCN1 in male offspring
    Wanwen Mai, Dong Peng, Luyi Wu, Ning Gao, Xiang Zhang, Runze Zhang, Rongyao Chen, Xinyi Zhong, Hongxia Chen, Qiuling Xie et al. · 2025 · Ecotoxicology and Environmental Safety
54. Unraveling the Function of PPARα in Neurodegenerative Disorders: A Potential Pathway to Novel Therapies
    Ourania-Natalia Galanou, Maria Konstandi · 2025 · Biomedicines
55. Synthesis, characterization, and neuroprotective effect of taxifolin-conjugated gold nanoparticles against amyloid βeta induced Alzheimer’s disease
    Bharathi Kalyanam, Shaheen Begum · 2025 · Letters in Drug Design & Discovery
56. Neuroinflammation demonstrated by 11 C‐ER176 PET with amyloid and tau pathology
    Mahathi Kandimalla, Seokbeen Lim, David N Jacobson, Jeyeon Lee, Paul H. Min, Marin Nycklemoe, Seung Baek Lee, Emily S. Lundt, Hugo Botha, Jonathan Graff‐Radford et al. · 2026 · Alzheimer s & Dementia
57. Processing-induced changes in neuroprotective components and mechanisms of gardeniae fructus: integrating UPLC-Q-TOF-MS/MS, network pharmacology, and in vitro analysis
    Le Sun, Ziyu Hou, Wenjie Wang, Peiling Wu, Pei Ma, Jiali Huang, Leyang Fan, Lijia Xu, Haibo Liu, Pei‐Gen Xiao · 2026 · Bioresources and Bioprocessing
58. Loss of REST associated with Alzheimer's disease pathology is ameliorated by NAD+
    Mariá José Lagartos-Donate, Beatriz Escobar-Doncel, Shi-qi Zhang, Jun‐Ping Pan, N. González, Alexander S. Anisimov, Nicola Pietro Montaldo, Vidar Jensen, Lipeng Mao, Bailei Li et al. · 2025 · Brain
59. Microbiota–Gut–Brain Axis in Alzheimer’s Disease: Linking Oxidative Stress, Mitochondrial Dysfunction and Amyloid Pathology—A Systematic Review
    Shah Rezlan Shajahan, Nurhidayah Hamid, Blaire Okunsai, Norshafarina Binti Shari, Muhammad Danial Che Ramli · 2026 · Biomedicines
60. Aluminum chloride in Alzheimer's disease: A dual focus on molecular mechanisms and rat experimental models
    Nourhan A. Khattab, Aya Hassan El-Kadem, Ahmed E. Goda, Nageh Ahmed El‐Mahdy, Nagla A. El‐Shitany · 2026 · Experimental Neurology
61. Molecular Mechanisms Underlying Alzheimer’s Disease Pathogenesis: Comprehensive Overview
    Filomena Lo Vecchio, Annamaria la Torre, Carolina Gravina, Grazia D’Onofrio, A Greco · 2026 · International Journal of Molecular Sciences
62. Prospective approach of Swietenia macrophylla as a neuroprotective agent for Alzheimer’s Disease: Emphasis on ameliorative mechanism
    Imrana Jazuli, Goh Bey Hing, Lakshmi Selvaratnam, Lee Learn Han, Deepa Alex, Yatinesh Kumari · 2023 · Journal of Functional Foods
63. Effects of early tooth loss on chronic stress and progression of neuropathogenesis of Alzheimer’s disease in adult Alzheimer’s model AppNL-G-F mice
    Suzuko Ochi, Kumiko Yamada, Takashi Saito, Takaomi C. Saido, Mitsuo Iinuma, Kagaku Azuma, Kin‐ya Kubo · 2024 · Frontiers in Aging Neuroscience
64. Discovery of fluorescent and theranostic probes for glycogen synthase kinase-3β in living cells and brain tissues: Detection and imaging in models of Alzheimer's disease
    Yu Chen, Hanyue Dong, 黄筱玲, Lulu Jiang, Zixing Jiang, Lanqing Li, Jinhui Hu, Wen-Hua Chen · 2025 · European Journal of Medicinal Chemistry
65. Bilirubin: a game-changer in alzheimer’s therapy? Unveiling its neuroprotective and disease-modifying potential
    Ramandeep Kaur Sidhu, Yukti Mittal, Khadga Raj Aran · 2025 · Metabolic Brain Disease
66. Tauopathies: Calmodulin Regulates Tau Hyperphosphorylation and Its Transformation into Disease-Specific Aggregates
    Danton H. O’Day · 2025 · Biomolecules
67. Role of dietary phytopharmaceuticals across the globe to alleviate the Alzheimer’s disease: mechanism-based approach
    Arun Kumar Mishra, Amrita Mishra, Kamal YT, Arvind Kumar, Harpreet Singh, Shristy Verma, Gyas Khan · 2025 · Phytomedicine Plus
68. Direct and indirect role of non-coding RNAs in company with amyloid and tau protein in promoting neuroinflammation in post-ischemic brain neurodegeneration
    Ryszard M. Pluta · 2025 · Frontiers in Cellular Neuroscience
69. Bridging the gap in the management of Alzheimer's disease using fecal microbiota transplantation
    Bushra Bashir, Monica Gulati, Sukriti Vishwas, Md Sadique Hussain, Gaurav Gupta, Puneet Kumar, Poonam Negi, Neeraj Mittal, Kamal Dua, Sachin Kumar Singh · 2025 · Molecular and Cellular Neuroscience
70. Experimental modeling for tauopathies: An isogenic panel of humanized MAPT knock-in mice
    Takahiro Morito, Naoto Watamura · 2025 · Neuroscience Research
71. Generating PET scan patterns in Alzheimer’s by a mathematical model
    Chaeyoung Lee, Avner Friedman · 2024 · PLoS ONE
72. Biological effects and mechanism of β-amyloid aggregation inhibition by penetrable recombinant human HspB5-ACD structural domain protein
    Chang Liu, Xuying Ding, Meijun Zhao, Chen Chen, Xiaojun Zhang, Risheng Zhao, Yutong Chen, Yining Xie · 2024 · Biomedicine & Pharmacotherapy
73. Inhibition of CXCR4: A perspective on miracle fruit seed for Alzheimer's disease treatment
    Xueyan Huang, Lu‐Lu Xue, Ruifang Ma, Jingshan Shi, Ting‐Hua Wang, Liu‐Lin Xiong, Changyin Yu · 2024 · Experimental Neurology
74. Interplay between glypican-1, amyloid-β and tau phosphorylation in human neural stem cells
    Fang Cheng, Lars‐Âke Fransson, Katrin Mani · 2024 · Neuroscience
75. Correlation Between the Fractional Amplitude of Low-Frequency Fluctuation and Cognitive Defects in Alzheimer’s Disease
    Xuemei Zhang, Jie You, Qun Qao, Xinyang Qi, Jingping Shi, Junrong Li · 2024 · Journal of Alzheimer s Disease
76. Network Diffusion-Constrained Variational Generative Models for Investigating the Molecular Dynamics of Brain Connectomes Under Neurodegeneration
    Jiajia Xie, Raghav Tandon, Cassie S. Mitchell · 2025 · International Journal of Molecular Sciences
77. Huannao Yicong decoction ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by interfering with neurotoxic interaction of Aβ-tau
    Huiqin Zhang, Wenxuan Chen, Zehui Li, Qiaoyi Huang, Jiayu Wen, Surui Chang, Hui Pei, Lina Ma, Hao Li · 2023 · Journal of Ethnopharmacology
78. LncRNA ENST00000440246.1 Promotes Alzheimer’s Disease Progression by Targeting PP2A
    Shang Gao, Fan Chang, Yongzhong Wang, Wenming Yang, Hui Jiang · 2023 · Biochemical Genetics
79. Obesity Facilitates Sex-Specific Improvement In Cognition And Neuronal Function In A Rat Model Of Alzheimer’s Disease
    Aaron Y. Lai, Dustin Loren Almanza, Jessica A. Ribeiro, Mary Elizabeth Hill, Matthew Mandrozos, Margaret M. Koletar, Bojana Stefanovic, JoAnne McLaurin · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
80. Self-assembled low molecular weight chitosan-bilobalide microsuspension protects hippocampal toxicity in amyloid beta(25–35) induced mice
    Prabhat Kumar, K.V. Harish Prashanth · 2024 · Carbohydrate Polymer Technologies and Applications
81. ApoE-T807-modified tanshinone IIA liposomes enhance cognitive function in APP/PS1 mice by inhibiting Tau phosphorylation via the PI3K/AKT signaling pathway
    Xiaofeng Wang, Lin Cui, Liang Kong, Sa-feng Zou, Xusheng Zhao · 2025 · Journal of Drug Delivery Science and Technology
82. Modulatory Effects of Urtica dioica on Neurodegenerative Diseases: Unveiling the Latest Findings and Applications Related to Neuroinflammation, Oxidative Stress, and Cognitive Dysfunction
    Ahlem Chira, Stefano Lorenzetti · 2025 · Antioxidants
83. Development of a light-initiated chemiluminescence system for the detection of human plasma p-tau181
    Yang Yang, Xu Wang · 2025 · The Analyst
84. The Biomarker Profile of Alzheimer’s Disease for Disease-Modifying Treatment Eligibility: Questions and Debates
    Athanasia Athanasaki, Ioanna Tsantzali, Aikaterini Theodorou, Amalia Michalopoulou, Vasilios C. Constantinides, Fotini Boufidou, John S. Tzartos, Panagiota‐Eleni Tsalouchidou, Christina Zompola, Sotirios G. Paraskevas et al. · 2025 · International Journal of Molecular Sciences
85. ER-Aβ dual-targeting NIRF/photoacoustic probe reveals Aβ-induced ER-stress via real-time viscosity imaging for early Alzheimer's disease diagnosis
    Xue Zhang, Jiaxin Cao, Xinyue Li, Zhiwen Zhao, Zhi‐Ren Zhang, Ning Li, Yuhong Jing, Baodui Wang · 2025 · Biomaterials
86. Deciphering the three-dimensional biomolecular distribution in the Alzheimer's disease brain: A multiomic approach integrating immunohistochemistry with MALDI MS imaging
    Kelly H. Lu, Hua Zhang, Gargey B. Yagnik, Mark J. Lim, Kenneth J. Rothschild, Wei Li, Andrew J. Schneider, Luigi Puglielli, Lingjun Li · 2025 · Analytica Chimica Acta
87. Arabinoxylan ameliorates memory deficits and amyloid pathology in male 5 × FAD mice via modulation of gut microbiota structure
    Kai Hu, C. Li, Yuxiang Liu, Changxu Pan, Peijun Xie, Lu Wen, Haotian Xu, Yue Tang, Peng Zheng, Yu Huang · 2025 · Neuroscience
88. Therapeutic Potentials of the Seaweed-Derived Compounds for Alzheimer’s Disease
    Keanie Ward, Michael H. Cole, Lyn Robyn Griffiths, Heidi G. E. Sutherland, Pia C. Winberg, Barbara J. Meyer, Francesca Fernandez · 2025 · Molecules
89. DHCR24 knockdown-induced cellular cholesterol deficiency triggers tau hyperphosphorylation at Thr181, Ser199 and Ser202/Thr205 via p38 MAPK/JNK signaling
    Mengqi Zhang, Wenshi Wei, Hengbing Zu · 2025 · Cellular Signalling
90. Multi-biofluid metabolomics coupled with gene network reveals stage-specific alterations in mild cognitive impairment and Alzheimer’s disease in an ethnically mixed cohort
    André Simões Cadaxo, Juliana Cordovil Cotrin, Ana Paula Valente, Flávia Gomes Lopes, Renato Peixoto Veras, Daniel Simplício Torres, Raquel Quimas Molina da Costa, Gilson Costa dos Santos, Cíntia Barros Santos-Rebouças · 2026 · Brain Research
91. IL-27, a metabolic regulator secreted by astrocytes in response to GLP-1RA OHP2, modulates microglial reprogramming in Alzheimer’s disease by regulating cGAS lactylation
    Yixuan Du, Lingxi Wu, Yang Mao, Song Chen, Xiangdong Gao · 2026 · Journal of Neuroinflammation
92. Epigallocatechin Gallate and Punicalagin Combination Reduces Aβ Aggregation and Promotes Neurogenesis in Adult Zebrafish Brain
    Dilek Nazli, Dogac Ipekgil, Yusuf Kaan Poyraz, Kubilay Can, Ilke Okmen, Ebru Turhanlar‐Sahin, Belgin Sert Serdar, Semra Koçtürk, Gunes Ozhan · 2026 · Journal of Neuroscience Research
93. β-Asarone Mediates the Alleviation of Neuroinflammation in Alzheimer’s Disease Via Modulation of the TREM2/PI3K/AKT Signaling Pathway
    Na Yang, Jiajun Jiang, Jianhong Shi, Xia Liu, Chenshi Yu, Shunyuan Guo, Chengliang Zhang, Feng Gao, Zijian Yang, Huina Feng et al. · 2026 · Inflammation
94. Phytotherapy for ageing-related multimorbidity: Systems-level insights into Centella asiatica in diabetes and Alzheimer’s Disease
    Sandesh Kumar Pattanaik, Debajani Mohanty, Asit Ray, Sudipta Jena, Sovan Pattanaik, Diptirani Rath · 2026 · Phytomedicine
95. Efficacy and mechanisms of Icariin in the treatment of Alzheimer's disease: a systematic review and meta-analysis of a preclinical study
    Jingdong Cui, Rui Huang, Xiaoyu Dong · 2026 · European Journal of Pharmacology
96. ALKBH3 m1A Demethylase Deficiency Reduces Alzheimer's Amyloid‐β Pathology
    Yueyang Li, S. M. Yu, Kaidong Lu, Yujie Zhang, Mingjie Dong, You Peng, Liang Xue, Waleed Alam, Yuxuan Shui, Yi Zhou et al. · 2026 · Advanced Science
97. Modulation of Tau Protein Neurotoxic Hallmarks by Novel σ 1 R Agonists/HDAC Inhibitor Dual‐Acting Compounds
    Antonino Nicolò Fallica, Carla Barbaraci, M. Carmen Ruiz‐Cantero, Arianna Scarlatti, Alessandro Coco, Giorgia Giordano, Alfonsina La Mantia, Orazio Prezzavento, Antonio Di Stefano, Ivana Cacciatore et al. · 2026 · ChemMedChem
98. MsDGCN: multi-scale diffusion graph convolutional network for the prediction of drug-disease association
    Xiaotong Kong, Yan Sun, Junliang Shang, Xiaohan Zhang, Xiaoqi Tang, Hanxiang Wang, Defu Qiu, Yuanke Zhang, Jin-Xing Liu · 2026 · Journal of Computer-Aided Molecular Design
99. Gentisic acid confers multimodal neuroprotection in experimental Alzheimer’s disease by targeting oxidative stress, neuroinflammation, and protein aggregation
    Urvashi Soni, Rohini Pujari · 2026 · Phytomedicine
100. Aquaporin‑4 polarization and glymphatic function in Alzheimer’s disease: Mechanisms, modulators, and therapeutic strategies
     Bingkang Huang, Guixian Tang · 2026 · Pathology - Research and Practice